Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.

Neeson PJ, Hsu AK, Chen YR, Halse HM, Loh J, Cordy R, Fielding K, Davis J, Noske J, Davenport AJ, Lindqvist-Gigg CA, Humphreys R, Tai T, Prince HM, Trapani JA, Smyth MJ, Ritchie DS.

Oncoimmunology. 2015 May 27;4(9):e1038011. eCollection 2015 Sep.

2.

Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.

Migone TS, Bolmer S, Zhong J, Corey A, Vasconcelos D, Buccellato M, Meister G.

Antimicrob Agents Chemother. 2015 Feb;59(2):1145-51. doi: 10.1128/AAC.04606-14. Epub 2014 Dec 8.

3.

Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials.

Furie R, Petri MA, Strand V, Gladman DD, Zhong ZJ, Freimuth WW; BLISS-52 and BLISS-76 Study Groups.

Lupus Sci Med. 2014 Jun 26;1(1):e000031. doi: 10.1136/lupus-2014-000031. eCollection 2014.

4.

Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.

Corey A, Migone TS, Bolmer S, Fiscella M, Ward C, Chen C, Meister G.

Toxins (Basel). 2013 Jan 14;5(1):120-38. doi: 10.3390/toxins5010120.

5.

Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.

Luster TA, Mukherjee I, Carrell JA, Cho YH, Gill J, Kelly L, Garcia A, Ward C, Oh L, Ullrich SJ, Migone TS, Humphreys R.

PLoS One. 2012;7(10):e47361. doi: 10.1371/journal.pone.0047361. Epub 2012 Oct 9.

6.

Fractional anisotropy distributions in 2- to 6-year-old children with autism.

Cascio C, Gribbin M, Gouttard S, Smith RG, Jomier M, Field S, Graves M, Hazlett HC, Muller K, Gerig G, Piven J.

J Intellect Disabil Res. 2013 Nov;57(11):1037-49. doi: 10.1111/j.1365-2788.2012.01599.x. Epub 2012 Sep 24.

7.

High cell density and productivity culture of Chinese hamster ovary cells in a fluidized bed bioreactor.

Kong D, Cardak S, Chen M, Gentz R, Zhang J.

Cytotechnology. 1999 May;29(3):215-20. doi: 10.1023/A:1008064217040.

8.

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo.

Pukac L, Kanakaraj P, Humphreys R, Alderson R, Bloom M, Sung C, Riccobene T, Johnson R, Fiscella M, Mahoney A, Carrell J, Boyd E, Yao XT, Zhang L, Zhong L, von Kerczek A, Shepard L, Vaughan T, Edwards B, Dobson C, Salcedo T, Albert V.

Br J Cancer. 2005 Apr 25;92(8):1430-41.

9.
10.

Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.

Sung C, Parry TJ, Riccobene TA, Mahoney A, Roschke V, Murray J, Gu ML, Glenn JK, Caputo F, Farman C, Odenheimer DJ.

AAPS PharmSci. 2002;4(2):E8.

11.

Modulation of T-cell responses to alloantigens by TR6/DcR3.

Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T, Feng P, Qi S, Chen H, Cho YH, Li Y, Moore PA, Wu J.

J Clin Invest. 2001 Jun;107(11):1459-68.

12.

A human TATA binding protein-related protein with altered DNA binding specificity inhibits transcription from multiple promoters and activators.

Moore PA, Ozer J, Salunek M, Jan G, Zerby D, Campbell S, Lieberman PM.

Mol Cell Biol. 1999 Nov;19(11):7610-20.

13.

Cell growth and protein formation on various microcarriers.

Kong D, Chen M, Gentz R, Zhang J.

Cytotechnology. 1999 Mar;29(2):151-8. doi: 10.1023/A:1008053421462.

14.

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F, Lincoln C, Endress G, Xing L, Wang S, Oh KO, Gentz R, Ruben S, Lippman ME, Hsieh SL, Yang D.

J Clin Invest. 1998 Sep 15;102(6):1142-51.

15.

p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family.

Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J.

Nucleic Acids Res. 1998 Sep 15;26(18):4121-8.

16.

Development of a versatile computer integrated control system for bioprocess controls.

Kong D, Gentz R, Zhang J.

Cytotechnology. 1998 May;26(3):227-36. doi: 10.1023/A:1007948313304.

17.

Long-term stable production of monocyte-colony inhibition factor (M-CIF) from CHO microcarrier perfusion cultures.

Kong D, Gentz R, Zhang J.

Cytotechnology. 1998 Mar;26(2):131-8. doi: 10.1023/A:1007997412002.

18.

Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors.

Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G.

J Exp Med. 1997 Apr 7;185(7):1163-72.

19.

Human stanniocalcin: a possible hormonal regulator of mineral metabolism.

Olsen HS, Cepeda MA, Zhang QQ, Rosen CA, Vozzolo BL, Wagner GF.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1792-6.

Supplemental Content

Loading ...
Support Center